Stanford Advisors


  • Le Cong, Postdoctoral Faculty Sponsor

All Publications


  • Surfaceome CRISPR activation screening uncovers ligands regulating tumor sensitivity to NK cell killing. Nature communications Dinesh, R. K., Wang, X., Mohammad, I. A., Gunasekaran, P., Stiklioraitis, K., Villafuerte, J. R., Rao, A., Hernandez-Lopez, R. A., Sunwoo, J. B., Cong, L. 2026; 17 (1)

    Abstract

    Natural killer (NK) cell-based immunotherapies are promising for cancer treatment due to their ability to eliminate cancer cells independently of antigen presentation and "off-the-shelf" utility. However, molecular determinants governing tumor susceptibility to NK cytotoxicity remain incompletely understood. Here we employ CRISPR activation (CRISPRa) screening to identify cancer cell surface regulators of NK killing. Using a surfaceome-focused library, we screen human and murine cancer cell lines co-cultured with NK cells, identifying known and novel ligands modulating NK cytotoxicity. Screens reveal established factors including CD43 and previously uncharacterized regulators CD44, PDPN, and Siglec-1/CD169. Validation with orthogonal approaches confirm that disruption of these factors alters NK killing susceptibility in vitro and in humanized mouse models. Mechanistically, we find that CD43-mediated NK resistance operates independently of its proposed interaction with Siglec-7, and that targeting CD43 on NK cells or CAR T cells substantially enhances cytotoxic activity against leukemia. These results establish gain-of-function surfaceome screening as a powerful tool for identifying therapeutic targets for NK cell-based immunotherapy.

    View details for DOI 10.1038/s41467-026-76374-x

    View details for PubMedID 42686754

    View details for PubMedCentralID 6474200

  • Programmable RNA translation through deep learning-driven IRES discovery and de novo generation NATURE MACHINE INTELLIGENCE Chu, Y., Yin, D., Yu, D., Xu, G., Zhang, J., Wang, X., Shen, Y., Li, Y., Zhao, N., Zhu, Y., Zhang, J., Goodarzi, H., Wang, M., Cong, L. 2026; 8 (4)
  • CRISPR-GPT for agentic automation of gene-editing experiments. Nature biomedical engineering Qu, Y., Huang, K., Yin, M., Zhan, K., Liu, D., Yin, D., Cousins, H. C., Johnson, W. A., Wang, X., Shah, M., Altman, R. B., Zhou, D., Wang, M., Cong, L. 2025

    Abstract

    Performing effective gene-editing experiments requires a deep understanding of both the CRISPR technology and the biological system involved. Meanwhile, despite their versatility and promise, large language models (LLMs) often lack domain-specific knowledge and struggle to accurately solve biological design problems. We present CRISPR-GPT, an LLM agent system to automate and enhance CRISPR-based gene-editing design and data analysis. CRISPR-GPT leverages the reasoning capabilities of LLMs for complex task decomposition, decision-making and interactive human-artificial intelligence (AI) collaboration. This system incorporates domain expertise, retrieval techniques, external tools and a specialized LLM fine tuned with open-forum discussions among scientists. CRISPR-GPT assists users in selecting CRISPR systems, experiment planning, designing guide RNAs, choosing delivery methods, drafting protocols, designing assays and analysing data. We showcase the potential of CRISPR-GPT by knocking out four genes with CRISPR-Cas12a in a human lung adenocarcinoma cell line and epigenetically activating two genes using CRISPR-dCas9 in a human melanoma cell line. CRISPR-GPT enables fully AI-guided gene-editing experiment design and analysis across different modalities, validating its effectiveness as an AI co-pilot in genome engineering.

    View details for DOI 10.1038/s41551-025-01463-z

    View details for PubMedID 40738974

    View details for PubMedCentralID 10876664

  • Membrane-wide screening identifies potential tissue-specific determinants of SARS-CoV-2 tropism. PLoS pathogens Dinesh, R. K., Wang, C., Qu, Y., Rustagi, A., Cousins, H., Zengel, J., Wang, X., Barnard, T. R., Johnson, W. A., Xu, G., Zhang, T., Magazine, N., Beck, A., Heilbroner, L. M., Peters-Schulze, G., Wilk, A. J., Wang, M., Huang, W., Howitt, B., Carette, J., Altman, R., Blish, C. A., Cong, L. 2025; 21 (7): e1013157

    Abstract

    While SARS-CoV-2 primarily infects the respiratory tract, clinical evidence indicates that cells from diverse cell types and organs are also susceptible to infection. Using the CRISPR activation (CRISPRa) approach, we systematically targeted human membrane proteins in cells with and without overexpression of ACE2, thus identifying unrecognized host factors that may facilitate viral entry. Validation experiments with replication-competent SARS-CoV-2 confirmed the role of newly identified host factors, particularly the endo-lysosomal protease legumain (LGMN) and the potassium channel KCNA6, upon exogenous overexpression. In orthogonal experiments, we show that disruption of endogenous LGMN or KCNA6 decreases viral infection and that inhibitors of candidate factors can reduce viral entry. Additionally, using clinical data, we find possible associations between expression of either LGMN or KCNA6 and SARS-CoV-2 infection in human tissues. Our results identify potentially druggable host factors involved in SARS-CoV-2 entry, and demonstrate the utility of focused, membrane-wide CRISPRa screens in uncovering tissue-specific entry factors of emerging pathogens.

    View details for DOI 10.1371/journal.ppat.1013157

    View details for PubMedID 40674406

  • FoldMark: Protecting Protein Generative Models with Watermarking. bioRxiv : the preprint server for biology Zhang, Z., Jin, R., Fu, K., Cong, L., Zitnik, M., Wang, M. 2024

    Abstract

    Protein structure is key to understanding protein function and is essential for progress in bioengineering, drug discovery, and molecular biology. Recently, with the incorporation of generative AI, the power and accuracy of computational protein structure prediction/design have been improved significantly. However, ethical concerns such as copyright protection and harmful content generation (biosecurity) pose challenges to the wide implementation of protein generative models. Here, we investigate whether it is possible to embed watermarks into protein generative models and their outputs for copyright authentication and the tracking of generated structures. As a proof of concept, we propose a two-stage method FoldMark as a generalized watermarking strategy for protein generative models. FoldMark first pretrain watermark encoder and decoder, which can minorly adjust protein structures to embed user-specific information and faithfully recover the information from the encoded structure. In the second step, protein generative models are fine-tuned with Low-Rank Adaptation modules with watermark as condition to preserve generation quality while learning to generate watermarked structures with high recovery rates. Extensive experiments are conducted on open-source protein structure prediction models (e.g., ESMFold and MultiFlow) and de novo structure design models (e.g., FrameDiff and FoldFlow) and we demonstrate that our method is effective across all these generative models. Meanwhile, our watermarking framework only exerts a negligible impact on the original protein structure quality and is robust under potential post-processing and adaptive attacks.

    View details for DOI 10.1101/2024.10.23.619960

    View details for PubMedID 39554012

    View details for PubMedCentralID PMC11565776

  • Systematic Discovery, In Vivo Delivery, and DNA Repair Mechanism of Single-Strand Annealing Protein for Precision Integration of Large DNA Sequences Cong, L., Yin, D., Xu, G., Qu, Y., Wang, C., Wang, X., Johnson, W., Filsinger, G., Wannier, T., Church, G. M., Phoon, L., Gao, B., Lan, L. CELL PRESS. 2024: 9-10
  • Long sequence insertion via CRISPR/Cas gene-editing with transposase, recombinase, and integrase. Current opinion in biomedical engineering Wang, X., Xu, G., Johnson, W. A., Qu, Y., Yin, D., Ramkissoon, N., Xiang, H., Cong, L. 2023; 28

    Abstract

    CRISPR/Cas-based gene-editing technologies have emerged as one of the most transformative tools in genome science over the past decade, providing unprecedented possibilities for both fundamental and translational research. Following the initial wave of innovations for gene knock-out, epigenetic/RNA modulation, and nickase-mediated base-editing, recent efforts have pivoted towards long-sequence gene editing- specifically, the insertion of large fragments (>1 kb) into the endogenous genome. In this review, we survey the development of these CRISPR/Cas-based sequence insertion methodologies in conjunction with the emergence of novel families of editing enzymes, such as transposases, single-stranded DNA-annealing proteins, recombinases, and integrases. Despite facing a number of challenges, this field continues to evolve rapidly and holds the potential to catalyze a new wave of revolutionary biomedical applications.

    View details for DOI 10.1016/j.cobme.2023.100491

    View details for PubMedID 38549686

    View details for PubMedCentralID PMC10976843

  • Metagenomic Mining and Engineering of Single-Strand Annealing Proteins for Cleavage-Free Genomic Knock-In of Long Sequence in Mouse Hepatocytes via dCas9 Targeting Wang, C., Xiang, H., Wang, X., Xu, G., Johnson, W., Le Cong CELL PRESS. 2023: 140-141